"Making Science Computable"

The Covid-19 Knowledge Accelerator is now the Health Evidence Knowledge Accelerator!

• Content and support tools for making science computable and facilitating HEvKA projects can be found on the Fast Evidence Interoperability Resources (FEvIR) Platform.

• The FEvIR HEvKA Project Page can be found at https://fevir.net/resources/Project/29272 and includes examples of evidence-related resources in current (R5) FHIR format.

Click on the images below to be redirected to each 3 minute lightening talk!

Google Drive folder for COKA

Click on the images below for introductory information about HEvKA

• Email balper@computablepublishing.com to be added to the HEvKA distribution list (daily email update of HEvKA activities)

• Join an expert working group for code system development -- see Invitation to join Expert Working Group. 

• Join us at any of the meetings listed on the left side of the screen by clicking on the following link: 

  Join Microsoft Teams Meeting (see meeting schedule below)

• We look forward to seeing you there!

You are welcome to join us!

Please email balper@computablepublishing.com with any questions.

For all of the above meetings: Join Microsoft Teams Meeting

+1 929-346-7156   United States, New York City (Toll)

Conference ID: 324 918 025#

Local numbers

Meeting support by Computable Publishing LLC

• 8 am Eastern: Project Management – review FHIR Trackers and IG preparations
• 9 am Eastern: Setting the SRDR Platform on FHIR Working Group – review FEvIR: SRDR+ Project Importer
• 10 am Eastern: ResearchOnFHIR Working Group – continue learning about FHIRPath and CQL

Tuesday, February 7:

• 9 am Eastern: Measuring the Rate of Scientific Knowledge Transfer Working Group – initial metrics development protocol
• 11 am Eastern: FEvIR Metadata Framework Working Group – develop Profile representation on FEvIR Platform
• 1 pm Eastern: Statistic Standard and Terminology (new time) – represent Measures of Dispersion in Evidence Resource model and Scientific Evidence Code System
• 2 pm Eastern: Research Design Working Group – review in-form-for-submission draft article for peer-reviewed publication

Wednesday, February 8:

• 8 am Eastern: Knowledge Ecosystem Liaison Working Group – attention to guideline updating with MAGIC
• 12 pm Eastern: HL7 Clinical Decision Support Work Group - agenda may include EBMonFHIR Trackers

Thursday, February 9:

• 8 am Eastern: EBM Implementation Guide Working Group (HL7 CDS EBMonFHIR sub-WG) – StudyOutcomeEvidence Profile of Evidence Resource
• 9 am Eastern: Computable EBM Tools Development Working Group – review FEvIR™: Adaptation Builder/Viewer
• 12 pm Eastern: HL7 Biomedical Research and Regulation Work Group - FHIR Representation of Eligibility Criteria for Clinical Trials project – consider Characteristic Resource
• 4 pm Eastern: Project Management – prepare weekly agenda

Friday, February 10:

• 8 am Eastern: GRADE Vocabulary Working Group – Continue GRADE Vocabulary Development Methods Protocol from step 6
• 9 am Eastern: Risk of Bias Terminology and Tooling Working Group – continue review and addition of terms and definitions to the Scientific Evidence Code System; attention to Reporting Bias terms
• 10 am Eastern: Communications Working Group – review progress on publications, presentations, and website
• 12 pm Eastern: Eligibility Criteria Working Group – review of Characteristic Resource and/or Eligibility Criteria Matching Software Library

• EXAMPLES showcasing current FHIR format include:
• Evidence Resource (meta-analysis finding) at https://fevir.net/resources/Evidence/55, corresponding Citation Resource at https://fevir.net/resources/Citation/58
• Evidence Resource (randomized trial finding) at https://fevir.net/resources/Evidence/7637, corresponding Citation Resource at https://fevir.net/resources/Citation/7638
• EvidenceReport Resource (“COKA-EBM Clinical Outcomes in ACTT-1 Remdesivir RCT EvidenceReport”) at https://fevir.net/resources/EvidenceReport/156 fully supported with 9 Evidence Resources, 7 EvidenceVariable Resources, 2 Group Resources, and 1 ActivityDefinition Resource
• EvidenceReport Resource (“Anticoagulation for Non-critically ill COVID-19 Multiplatform RCT EvidenceReport”) at https://fevir.net/resources/EvidenceReport/18816
• EvidenceReport Resource (“Anticoagulation for Non-critically ill COVID-19 Individual RCTs Table EvidenceReport”) at https://fevir.net/resources/EvidenceReport/18831
• EvidenceReport Resource (“Anticoagulation for Non-critically ill COVID-19 Summary of Findings from RCTs Table EvidenceReport”) at https://fevir.net/resources/EvidenceReport/18881